Docetaxel/Cyclophosphamide-induced ultraviolet recall dermatitis.
Saints Cancer Center, 2 Hospital Drive, Lowell, MA 01852, USA. fbasile@saintsmed.org
Frank G
FG
Basile
Sandra
S
Creamer
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D044584:Carcinoma, Ductal / Q000150:complications / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D003872:Dermatitis / Q000150:complications*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D012008:Recurrence; D013471:Sunburn / Q000150:complications*; D043823:Taxoids / Q000008:administration & dosage / Q000009:adverse effects*
D043823:Taxoids; D000077143:Docetaxel; D003520:Cyclophosphamide